Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study

被引:11
|
作者
Kumar, Kanta [1 ,2 ]
Peters, Sarah [3 ]
Barton, Anne [2 ,4 ]
机构
[1] Univ Manchester, Sch Hlth Sci, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Inst Inflammat & Repair, Manchester M13 9PL, Lancs, England
[3] Manchester Ctr Hlth Psychol, Sch Hlth Sci, Manchester M13 9PL, Lancs, England
[4] Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal BRU, Manchester, Lancs, England
关键词
Rheumatoid arthritis; Predictive testing; Patient perspective; PSYCHOLOGICAL IMPACT; SOCIETY; TRIAL; RISK;
D O I
10.1186/s12891-016-1319-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Rheumatoid arthritis (RA) is a long term condition that requires early treatment to control symptoms and improve long-term outcomes. Lack of response to RA treatments is not only a waste of healthcare resources, but also causes disability and distress to patients. Identifying biomarkers predictive of treatment response offers an opportunity to improve clinical decisions about which treatment to recommend in patients and could ultimately lead to better patient outcomes. The aim of this study was to explore the understanding of and factors affecting Rheumatoid Arthritis (RA) patients' decisions around predictive treatment testing. Methods: A qualitative study was conducted with a purposive sample of 16 patients with RA from three major UK cities. Four focus groups explored patient perceptions of the use of biomarker tests to predict response to treatments. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis by three researchers. Results: Data were organised within three interlinking themes: [1] Perceptions of predictive tests and patient preference of tests; [2] Utility of the test to manage expectations; [3] The influence of the disease duration on take up of predictive testing. During consultations for predictive testing, patients felt they would need, first, careful explanations detailing the consequences of untreated RA and delayed treatment response and, second, support to balance the risks of tests, which might be invasive and/or only moderately accurate, with the potential benefits of better management of symptoms. Conclusions: This study provides important insights into predictive testing. Besides supporting clinical decision making, the development of predictive testing in RA is largely supported by patients. Developing strategies which communicate risk information about predictive testing effectively while reducing the psychological burden associated with this information will be essential to maximise uptake.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [11] Patient access to rheumatoid arthritis treatments
    Bengt Jönsson
    Gisela Kobelt
    Josef Smolen
    The European Journal of Health Economics, 2008, 8 : 33 - 34
  • [12] Patient access to rheumatoid arthritis treatments
    Joensson, Bengt
    Kobelt, Gisela
    Smolen, Josef
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S33 - S34
  • [13] Patient access to rheumatoid arthritis treatments
    Bengt Jönsson
    The European Journal of Health Economics, 2008, 8 : 35 - 38
  • [14] Stakeholder perceptions of preventive approaches to rheumatoid arthritis: qualitative study of healthcare professionals' perspectives on predictive and preventive strategies
    Wells, Imogen
    Simons, Gwenda
    Kanacherril, Jasin Philip
    Mallen, Christian D.
    Raza, Karim
    Falahee, Marie
    BMC RHEUMATOLOGY, 2023, 7 (01)
  • [15] Stakeholder perceptions of preventive approaches to rheumatoid arthritis: qualitative study of healthcare professionals’ perspectives on predictive and preventive strategies
    Imogen Wells
    Gwenda Simons
    Jasin Philip Kanacherril
    Christian D. Mallen
    Karim Raza
    Marie Falahee
    BMC Rheumatology, 7
  • [16] PATIENTS′ PERCEPTIONS OF LIFESTYLE INTERVENTIONS IN EARLY RHEUMATOID ARTHRITIS - A QUALITATIVE STUDY
    Af Hagelsrum, K. Drake
    Larsson, I.
    Bremander, A.
    Lindqvist, E.
    Mogard, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 252 - 252
  • [17] The use of glucocorticoids in early rheumatoid arthritis GCs versus other treatments and patient perceptions
    Verschueren, Patrick
    Westhovens, Rene
    RHEUMATOLOGY, 2018, 57 (08) : 1316 - 1317
  • [18] QUALITY OF LIFE IN PATIENT WITH ESTABLISHED RHEUMATOID ARTHRITIS: A QUALITATIVE STUDY
    Malm, K.
    Bremander, A.
    Andersson, M. L. E.
    Bergman, S.
    Larsson, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1308 - 1308
  • [19] Patient Perspectives on Tapering Treatment in Rheumatoid Arthritis: A Qualitative Study
    Hazlewood, Glen
    Hull, Pauline
    Sirois, Alexandra
    Bykerk, Vivian
    Pope, Janet
    Schieir, Orit
    Loyola-Sanchez, Adalberto
    Barnabe, Cheryl
    Barber, Claire
    Marshall, Deborah
    Stevenson, Martina
    Richards, Dawn
    Proulx, Laurie
    Bartlett, Susan
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 805 - 806
  • [20] Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis
    Karin Schölin Bywall
    Jorien Veldwijk
    Mats G. Hansson
    Ulrik Kihlbom
    The Patient - Patient-Centered Outcomes Research, 2019, 12 : 297 - 305